Azzad Asset Management Inc /Adv Biomarin Pharmaceutical Inc Transaction History

Azzad Asset Management Inc /Adv

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Apr 01, 2024	SELL	$80.93 - $108.63 $569,342 - $764,212	-7,035 Closed	0 $0
Q3 2022 Apr 01, 2024	SELL	$82.16 - $96.94 $82 - $96	-1 Reduced 0.01%	7,035 $868 Million
Q2 2022 Apr 01, 2024	BUY	$71.48 - $86.85 $502,933 - $611,076	7,036 New	7,036 $868 Million
Q3 2020 Apr 01, 2024	SELL	$71.87 - $131.03 $505,246 - $921,140	-7,030 Closed	0 $0
Q2 2020 Apr 01, 2024	SELL	$79.55 - $124.22 $159 - $248	-2 Reduced 0.03%	7,030 $867 Million
Q1 2020 Apr 01, 2024	SELL	$71.37 - $96.85 $501,731 - $680,855	-7,030 Reduced 49.99%	7,032 $594 Million
Q3 2019 Apr 01, 2024	BUY	$67.4 - $85.11 $474,226 - $598,833	7,036 Added 100.14%	14,062 $1.34 Billion
Q2 2019 Apr 01, 2024	BUY	$80.35 - $93.9 $38,648 - $45,165	481 Added 7.35%	7,026 $602 Million
Q1 2019 Apr 01, 2024	BUY	$84.2 - $98.62 $28,459 - $33,333	338 Added 5.45%	6,545 $581 Million
Q2 2018 Apr 01, 2024	BUY	$76.01 - $99.03 $471,794 - $614,679	6,207 New	6,207 $585 Million
Q2 2017 Apr 03, 2024	SELL	N/A	-2,500 Reduced 29.94%	5,850 $531 Million
Q3 2015 Apr 03, 2024	SELL	N/A	-1,220 Reduced 12.75%	8,350 $879 Million
Q4 2014 Apr 03, 2024	BUY	N/A	1,469 Added 18.13%	9,570 $865 Million
Q3 2014 Apr 03, 2024	BUY	N/A	1,412 Added 21.11%	8,101 $585 Million
Q2 2014 Apr 03, 2024	SELL	N/A	-3,631 Reduced 35.18%	6,689 $416 Million
Q1 2014 Apr 03, 2024	BUY	N/A	2,265 Added 28.12%	10,320 $684 Million
Q3 2013 Apr 03, 2024	BUY	N/A	8,055	8,055 $581 Million

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Azzad Asset Management Inc /Adv, based on Form 13F filings with the SEC.

Stay updated on Azzad Asset Management Inc /Adv with notifications on news.